These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6117292)

  • 1. Pharmacokinetic and biopharmaceutical studies on azelastine hydrochloride in beagle dogs by quantitative selected-ion monitoring.
    Hasegawa J; Tomono Y; Tanaka M; Fujita T; Sugiyama K; Hirose N
    Arzneimittelforschung; 1981; 31(8):1215-20. PubMed ID: 6117292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of azelastine hydrochloride, a new antiallergic drug, on the gastrointestinal tract.
    Yamanaka T; Shoji T; Murakami M; Igarashi T
    Arzneimittelforschung; 1981; 31(8):1203-6. PubMed ID: 6117289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of an antiallergic agent, azelastine (4-(p-chlorobenzyl)-2-[N-methylperhydroazepinyl-(4)]-1-(2H)-p hthalazin one hydrochloride) in rats and guinea pigs.
    Tatsumi K; Yamada H; Yoshimura H; Nishizawa Y; Sakai M; Mizuo H; Yamato C
    Hiroshima J Med Sci; 1984 Dec; 33(4):669-78. PubMed ID: 6152559
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-allergic properties of a new histamine antagonist, 4-(p-chlorobenzyl)-2- [N-methyl-perhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride (azelastine).
    Tasaka K; Akagi M
    Arzneimittelforschung; 1979; 29(3):488-93. PubMed ID: 90510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
    Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
    Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of metabolic fate of a new antiallergic agent, azelastine (4-(p-chlorobenzyl)-2-[N-methylperhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride).
    Tatsumi K; Ou T; Yamada H; Yoshimura H
    Jpn J Pharmacol; 1980 Feb; 30(1):37-48. PubMed ID: 6105223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro identification of the human cytochrome P-450 enzymes involved in the N-demethylation of azelastine.
    Imai T; Taketani M; Suzu T; Kusube K; Otagiri M
    Drug Metab Dispos; 1999 Aug; 27(8):942-6. PubMed ID: 10421623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by azelastine of the immunologically induced histamine release from isolated guinea pig mast cells.
    Fischer B; Schmutzler W
    Arzneimittelforschung; 1981; 31(8):1193-5. PubMed ID: 6170297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of azelastine hydrochloride on vascular permeability in hypersensitivity reaction skin site in guinea pig.
    Tanigawa T; Honda M; Miura K
    Arzneimittelforschung; 1981; 31(8):1212-5. PubMed ID: 6117291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Synthesis of 14C-azelastine hydrochloride].
    Scheffler G; Beckel H; Schaumlöffel E
    Arzneimittelforschung; 1983; 33(11):1515-6. PubMed ID: 6686443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azelastine: a multifaceted drug for asthma therapy.
    Szelenyi I; Achterrath-Tuckermann U; Schmidt J; Minker E; Paegelow I; Werner H
    Agents Actions Suppl; 1991; 34():295-311. PubMed ID: 1686526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amezinium in rat and dog.
    Traut M; Brode E; Neumann B; Kummer H
    Arzneimittelforschung; 1981; 31(9a):1594-604. PubMed ID: 7197974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
    Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
    Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability, pharmacokinetics and dose linearity of azelastine hydrochloride in healthy subjects.
    Riethmüller-Winzen H; Peter G; Büker KM; Romeis P; Borbe HO
    Arzneimittelforschung; 1994 Oct; 44(10):1136-40. PubMed ID: 7818588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of papaverine hydrochloride and the biopharmaceutics of its oral dosage forms.
    Garrett ER; Roseboom H; Green JR; Schuermann W
    Int J Clin Pharmacol Biopharm; 1978 May; 16(5):193-208. PubMed ID: 649238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of (-)-clausenamide and its major metabolite 6-hydroxyl-clausenamide in beagle dogs by HPLC/MS].
    Song M; Qian W; Hang TJ; Zhang ZX
    Yao Xue Xue Bao; 2005 Oct; 40(10):940-4. PubMed ID: 16408814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of naltrexone hydrochloride and naltrexone glucuronide in the dog].
    Li H; Zhao SF; Wang N; Ge ZH
    Yao Xue Xue Bao; 1996; 31(4):254-7. PubMed ID: 9208648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.